EDP-239, a novel HCV NS5A inhibitor, demonstrates potent antiviral activity after a single dose treatment of genotype 1 HCV patients
Eric Lawitz,Fred Poordad,Juan Rondon,Terry D. Box,Stefan Zeuzem,Peter Buggisch,Kelly A. Wong,Christopher T. Jones, Carmen Ayala,Baldur Magnusson,Christopher M. Owens,Lijuan Jiang,Kai Lin, Kimberley Caliri, Kenneth Tack,Richard Colvin,Yat Sun Or HEPATOLOGY（2015）
AI 理解论文
溯源树
样例
